Rhonda Patrick· PhD
in a recent study nicotinamide mononucleotide was shown to accelerate cancer growth in mice with a type of pancreatic cancer where pro-inflammatory senescence cells drive tumor growth when mice were injected with 500 milligrams per kilogram body weight of nicotinamide mononucleotide for 13 days they exhibited significant increases in precancerous and cancerous lesions in the pancreas